Literature DB >> 7967365

Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6.

M E van den Dobbelsteen1, F J van der Woude, W E Schroeijers, A W van den Wall Bake, L A van Es, M R Daha.   

Abstract

The mesangium plays a crucial role in processes of inflammation in the kidney. Since deposits of IgA in the mesangium in patients with IgA nephropathy suggest a role for IgA in the inflammatory process, we investigated whether IgA is able to bind to cultured rat mesangial cells (MC) in vitro and induce activation of MC. As a source of IgA, monomeric (mIgA), dimeric (dIgA) and polymeric IgA-alpha-DNP (pIgA) rat monoclonal antibodies were used. FACS analysis indicated binding of dIgA and pIgA to MC while only a small percentage of the cells exhibited binding of mIgA. Additional experiments employing radiolabeled IgA revealed a time- and dose-dependent binding of 125I-dIgA and 125I-pIgA with 6 x 10(6) binding sites for dIgA with an affinity of 5.5 x 10(6) M-1 and 7.2 X 10(6) binding sites/cell for pIgA with an affinity of 1.2 x 10(6) M-1. As compared to 125I-dIgA and 125I-pIgA, little binding of 125I-mIgA to MC occurred; the binding of dIgA and pIgA was not influenced by excess cold BSA, IgG or asialofetuin. Since some studies have suggested that fibronectin might interact with IgA, the binding of IgA to MC in the presence or absence of fibronectin or the RGD fragment was also analyzed. However no influence of fibronectin or the RGD fragment on binding of dIgA and pIgA to MC was observed. As a measure for activation of MC by IgA, the production of IL-6 by MC was analyzed. Dimeric IgA and pIgA both induced a dose-dependent increase of IL-6 production by MC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967365     DOI: 10.1038/ki.1994.302

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Association of C4d deposition with clinical outcomes in IgA nephropathy.

Authors:  Mario Espinosa; Rosa Ortega; Marina Sánchez; Alfons Segarra; Maria Teresa Salcedo; Fayna González; Rafael Camacho; Miguel Angel Valdivia; Rocio Cabrera; Katia López; Fernando Pinedo; Eduardo Gutierrez; Alfonso Valera; Miryam Leon; Maria Angeles Cobo; Rosa Rodriguez; Jose Ballarín; Yolanda Arce; Beatriz García; María Dolores Muñoz; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

3.  Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.

Authors:  Y Wang; M-H Zhao; Y-K Zhang; X-M Li; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

4.  Comparison between C4d immunohistochemical staining and other clinical-histopathological findings in IgA nephropathy.

Authors:  Tala Pourlak; Seyyed Hamed Sharif Arani; Sima Abediazar; Hossein Samadi Kafil
Journal:  Biomedicine (Taipei)       Date:  2021-06-01

5.  Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells.

Authors:  T J Reterink; W E Schroeijers; L A Es; M R Daha
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

6.  Rs12976445 Polymorphism is Associated with Risk of Diabetic Nephropathy Through Modulating Expression of MicroRNA-125 and Interleukin-6R.

Authors:  Cunjie Li; Ting Lei
Journal:  Med Sci Monit       Date:  2015-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.